Medicare & Medicaid
High expenses have been placing added strain on hospitals as they try to recover from the challenges of the pandemic.
Two organizations protest that treatment is no more accessible than under the agency's current clinical trial policy.
A provision in the IRA would ameliorate the out-of-pocket spending increases when people transition from commercial insurance to Part D.
A full two-thirds of enrollees aren't sure if states can now remove people from Medicaid if they no longer meet eligibility.
Contracts with managed care plans would include a report on spread pricing, CMS says.
Patient demand could result in expanded coverage, but it could cost the federal program between $13.6 and $26.8 billion annually.
As a catalyst for the renewed push, lawmakers cited the lives lost during the COVID-19 pandemic.
Medicare annual spending on lecanemab's medication costs alone would place it among the most expensive Part B medications.
Humana framed the partnerships as part of a push to expand value-based care across its slate of home health services.
The requirements would result in federal savings, but would pass costs on to states and cause large coverage losses, data shows.